Bank of New York Mellon Corp Trims Stake in Nu Skin Enterprises, Inc. (NUS)

Bank of New York Mellon Corp trimmed its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 15.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 746,534 shares of the company’s stock after selling 138,723 shares during the period. Bank of New York Mellon Corp owned about 1.41% of Nu Skin Enterprises worth $45,896,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. BlackRock Inc. lifted its position in shares of Nu Skin Enterprises by 1.8% during the 2nd quarter. BlackRock Inc. now owns 6,805,093 shares of the company’s stock valued at $427,632,000 after acquiring an additional 121,562 shares during the period. Vanguard Group Inc. lifted its position in shares of Nu Skin Enterprises by 0.8% during the 2nd quarter. Vanguard Group Inc. now owns 6,060,437 shares of the company’s stock valued at $380,838,000 after acquiring an additional 48,805 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Nu Skin Enterprises by 6.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,067,875 shares of the company’s stock valued at $67,106,000 after acquiring an additional 64,767 shares during the period. Wasatch Advisors Inc. lifted its position in shares of Nu Skin Enterprises by 3.4% during the 2nd quarter. Wasatch Advisors Inc. now owns 638,396 shares of the company’s stock valued at $40,117,000 after acquiring an additional 20,957 shares during the period. Finally, Northern Trust Corp increased its stake in shares of Nu Skin Enterprises by 3.8% during the 2nd quarter. Northern Trust Corp now owns 529,506 shares of the company’s stock worth $33,274,000 after purchasing an additional 19,350 shares in the last quarter. Institutional investors own 77.54% of the company’s stock.

NUS has been the subject of a number of recent research reports. Zacks Investment Research cut shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Tuesday, October 17th. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Tuesday, November 14th. Three analysts have rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $62.00.

Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) traded up $0.01 on Wednesday, hitting $66.58. 376,400 shares of the stock were exchanged, compared to its average volume of 664,038. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.18 and a current ratio of 1.78. Nu Skin Enterprises, Inc. has a fifty-two week low of $46.35 and a fifty-two week high of $68.50. The stock has a market cap of $3,504.91, a PE ratio of 23.52, a price-to-earnings-growth ratio of 2.42 and a beta of 1.57.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Wednesday, November 1st. The company reported $0.76 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.76. Nu Skin Enterprises had a net margin of 6.97% and a return on equity of 22.38%. The business had revenue of $563.70 million during the quarter, compared to analysts’ expectations of $562.70 million. During the same period last year, the company posted $0.98 EPS. The company’s revenue was down 6.7% on a year-over-year basis. equities analysts expect that Nu Skin Enterprises, Inc. will post 3.23 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 6th. Stockholders of record on Friday, November 17th will be paid a dividend of $0.36 per share. The ex-dividend date is Thursday, November 16th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.16%. Nu Skin Enterprises’s dividend payout ratio (DPR) is 52.75%.

In other Nu Skin Enterprises news, insider Joseph Y. Chang sold 36,503 shares of Nu Skin Enterprises stock in a transaction that occurred on Friday, November 10th. The shares were sold at an average price of $62.24, for a total value of $2,271,946.72. Following the completion of the sale, the insider now directly owns 66,563 shares of the company’s stock, valued at approximately $4,142,881.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Daniel W. Campbell sold 4,607 shares of Nu Skin Enterprises stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $62.48, for a total transaction of $287,845.36. Following the completion of the sale, the director now directly owns 63,753 shares of the company’s stock, valued at $3,983,287.44. The disclosure for this sale can be found here. Over the last three months, insiders have sold 73,207 shares of company stock valued at $4,585,949. Corporate insiders own 5.20% of the company’s stock.

WARNING: “Bank of New York Mellon Corp Trims Stake in Nu Skin Enterprises, Inc. (NUS)” was posted by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.com-unik.info/2017/12/06/bank-of-new-york-mellon-corp-trims-stake-in-nu-skin-enterprises-inc-nus.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

What are top analysts saying about Nu Skin Enterprises Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Nu Skin Enterprises Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit